ATPW
GILD icon

Ashton Thomas Private Wealth’s Gilead Sciences GILD Stock Holding History

Ashton Thomas Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84M Buy
62,087
+2,502
+4% +$330K 0.16% 133
2026
Q1 		$8.3M Buy
59,585
+4,793
+9% +$671K 0.2% 111
2025
Q4 		$6.73M Sell
54,792
-3,184
-5% -$387K 0.16% 136
2025
Q3 		$6.44M Buy
57,976
+10,107
+21% +$1.15M 0.17% 145
2025
Q2 		$5.31M Buy
47,869
+2,101
+5% +$224K 0.19% 130
2025
Q1 		$5.13M Buy
45,768
+1,551
+4% +$160K 0.2% 127
2024
Q4 		$4.08M Buy
44,217
+932
+2% +$83.9K 0.16% 152
2024
Q3 		$3.63M Sell
43,285
-1,165
-3% -$88.9K 0.19% 134
2024
Q2 		$3.05M Buy
44,450
+818
+2% +$54.6K 0.17% 140
2024
Q1 		$3.2M Sell
43,632
-623
-1% -$47.9K 0.18% 145
2023
Q4 		$3.59M Buy
44,255
+75
+0.2% +$5.84K 0.23% 125
2023
Q3 		$3.31M Buy
44,180
+1,408
+3% +$108K 0.24% 119
2023
Q2 		$3.3M Buy
42,772
+1,617
+4% +$129K 0.25% 109
2023
Q1 		$3.41M Sell
41,155
-33,227
-45% -$2.75M 0.3% 84
2022
Q4 		$6.39M Buy
74,382
+1,010
+1% +$80K 0.63% 33
2022
Q3 		$4.53M Buy
73,372
+12,201
+20% +$769K 0.51% 42
2022
Q2 		$3.78M Buy
61,171
+12,420
+25% +$769K 0.41% 67
2022
Q1 		$2.9M Buy
48,751
+8,124
+20% +$519K 0.25% 113
2021
Q4 		$2.95M Buy
40,627
+22,157
+120% +$1.53M 0.29% 93
2021
Q3 		$1.29M Buy
18,470
+375
+2% +$26.3K 0.19% 124
2021
Q2 		$1.25M Buy
18,095
+7,647
+73% +$511K 0.19% 131
2021
Q1 		$675K Buy
+10,448
New +$674K 0.11% 196

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ashton Thomas Private Wealth's GILD Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Gilead Sciences (GILD) stake by 4.2% in Q2 2026, buying an estimated $330K and bringing the position to 62,087 shares worth $7.84M. The position accounts for 0.16% of the portfolio, ranked #133.

Ashton Thomas Private Wealth first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.3M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ashton Thomas Private Wealth held 62,087 shares of Gilead Sciences worth $7.84M as of Q2 2026.
  • Ashton Thomas Private Wealth bought 2,502 Gilead Sciences shares in Q2 2026, an estimated $330K.
  • Gilead Sciences made up 0.16% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #133 holding.
  • Ashton Thomas Private Wealth first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • Ashton Thomas Private Wealth's Gilead Sciences position peaked at $8.3M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.